Hear firsthand from originators behind several Flagship-founded companies about what it takes to build a bioplatform, why agility and iteration are so critical in the early days and beyond, and why team culture is an essential component on these journeys into the unknown to deliver big leaps for human health. Watch the full discussion featuring Flagship General Partner Avak Kahvejian and Flagship Origination Partners Kyle Chiang, Molly Gibson, and Jake Rubens.
More from:
Human Health

Pioneering Partnerships: Advancing a Portfolio of Novel Medicines and Vaccines with GSK

Pioneering Partnerships: Accelerating our Collaboration with Pfizer

Halting the Trajectory of Disease with Preemptive Health

AI in Action

2025 CEO Chat: Torben Straight Nissen, CEO of Repertoire Immune Medicines
